Search research articles
Contact Us
Filters
Showing results (331-340 of 401) with videos related to
Page
of 41
Sort By:
Journal of Neurochemistry
|
March 8, 2012
Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome
Xinglong Wang, Mike Snape, Eric Klann, et al.
Journal of Neuropathology and Experimental Neurology
|
June 14, 2011
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies
Jeremy G Stone, Sandra L Siedlak, Massimo Tabaton, et al.
Anesthesiology
|
August 1, 1996
Phenylephrine increases cerebral blood flow during low-flow hypothermic cardiopulmonary bypass in baboons
A E Schwartz, O Minanov, J G Stone, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2014
NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy
Thomas J Dougherty, Asha Nayar, Joseph V Newman, et al.
Transfusion
|
June 1, 1990
Surgeons' knowledge, attitude, and use of preoperative autologous blood donation
R G Strauss, K J Ferguson, G G Stone, et al.
Life Sciences
|
January 24, 1983
CGS 7525A, a new, centrally active alpha 2 adrenoceptor antagonist
J M Liebman, R A Lovell, A Braunwalder, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 3, 2005
Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae
Hong Yong, Yu Gui Gu, Richard F Clark, et al.
Anesthesiology
|
July 1, 1993
Cardiac performance preserved despite thiopental loading
J G Stone, W L Young, Z S Marans, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
April 20, 2021
Long-term follow-up of a patient with JAG1-associated retinopathy
Muhammad R Cheema, Lydia G Stone, Peter W Sellar, et al.
Infectious Diseases and Therapy
|
August 10, 2021
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program
John E Mazuski, Florian Wagenlehner, Antoni Torres, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 401) with videos related to
Sort By:
Page
of 41
Journal of Neurochemistry
|
March 8, 2012
Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome
Xinglong Wang, Mike Snape, Eric Klann, et al.
Journal of Neuropathology and Experimental Neurology
|
June 14, 2011
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies
Jeremy G Stone, Sandra L Siedlak, Massimo Tabaton, et al.
Anesthesiology
|
August 1, 1996
Phenylephrine increases cerebral blood flow during low-flow hypothermic cardiopulmonary bypass in baboons
A E Schwartz, O Minanov, J G Stone, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2014
NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy
Thomas J Dougherty, Asha Nayar, Joseph V Newman, et al.
Transfusion
|
June 1, 1990
Surgeons' knowledge, attitude, and use of preoperative autologous blood donation
R G Strauss, K J Ferguson, G G Stone, et al.
Life Sciences
|
January 24, 1983
CGS 7525A, a new, centrally active alpha 2 adrenoceptor antagonist
J M Liebman, R A Lovell, A Braunwalder, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 3, 2005
Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae
Hong Yong, Yu Gui Gu, Richard F Clark, et al.
Anesthesiology
|
July 1, 1993
Cardiac performance preserved despite thiopental loading
J G Stone, W L Young, Z S Marans, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
April 20, 2021
Long-term follow-up of a patient with JAG1-associated retinopathy
Muhammad R Cheema, Lydia G Stone, Peter W Sellar, et al.
Infectious Diseases and Therapy
|
August 10, 2021
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program
John E Mazuski, Florian Wagenlehner, Antoni Torres, et al.
Page
of 41